The typical receptors utilized in nanoparticle-based drug delivery for brain tumors includes transferrin receptor mediated transcytosis, low-density lipoprotein receptor-mediated transcytosis, insulin receptor-mediated transcytosis and nicotinic acetylcholine receptor-mediated transcytosis. The gene discussed is LDLR; the disease is brain neoplasm.